Paid Clinical Trials Colorado Springs

Discover 366 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 366

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Colorado Springs CO, Pueblo CO, Parker CO, Lone Tree COshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Colorado Springs CO, Englewood CO, Draper UT, Flagstaff AZshow 82 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisAn Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Littleton CO, Oklahoma City OK, Mesa AZ, Valencia CAshow 10 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Vafseo Outcomes In-Center ExperienceVafseo Outcomes In-Center Experience

Recruiting

PHASE3

Sponsor:

USRC Kidney Research

Location:

Lone Tree CO, Gallup NM, Dallas TX, Live Oak TXshow 1 more

Code:

NCT06520826

Conditions

Anemia of Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vadadustat

Erythropoiesis Stimulating Agent

Safety and Effectiveness of the PXL-Platinum 330 SystemSafety and Effectiveness of the PXL-Platinum 330 System

Recruiting

PHASE1

PHASE2

Sponsor:

Colorado Eye Consultants/Cornea Consultants of Colorado

Location:

Littleton CO, Highland Park IL, Brecksville OH

Code:

NCT04401865

Conditions

Corneal Ectasia

Keratoconus

Pellucid Marginal Corneal Degeneration

Eligibility Criteria

Sex: All

Age: 8+

Healthy Volunteers: Not accepted

Interventions

PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With AsthmaA Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Englewood CO, Wheat Ridge CO, West Jordan UT, Omaha NEshow 62 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsTo Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Recruiting

PHASE3

Sponsor:

Cerevance

Location:

Englewood CO, Tulsa OK, Kansas City KS, Georgetown TXshow 20 more

Code:

NCT06553027

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

CVN424 75 mg

CVN424 150 mg

Placebo

Comparison of Methods in Post Operative Hip Arthroscopy RehabilitationComparison of Methods in Post Operative Hip Arthroscopy Rehabilitation

Recruiting

Sponsor:

University of Colorado, Denver

Location:

Englewood CO

Code:

NCT05165927

Conditions

Hip Injuries

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

BFR

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisStudy to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting

PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Colorado Springs CO, West Jordan UT, Tucson AZ, Dallas TXshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Recruiting

Sponsor:

University of Colorado, Denver

Location:

Lone Tree CO, Aurora CO

Code:

NCT03958565

Conditions

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tyrosine Kinase Inhibitor

Zoledronic Acid 4 MG/100 ML Intravenous Solution [ZOMETA]

Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]